Association of asymptomatic spinal cord lesions and atrophy with disability 5 years after a clinically isolated syndrome von Brownlee, WJ, Altmann, DR, Alves Da Mota, P, Swanton, JK, Miszkiel, KA, Wheeler-Kingshott, CAM Gandini, Ciccarelli, O, Miller, DH

Volltext

Periventricular lesions and MS diagnostic criteria in young adults with typical clinically isolated syndromes von Brownlee, WJ, Miszkiel, KA, Altmann, DR, Ciccarelli, O, Miller, DH

Volltext

Antecedent anti-NMDA receptor encephalitis in two patients with multiple sclerosis von Baheerathan, A, Brownlee, WJ, Chard, DT, Shields, K, Gregory, R, Trip, SA

Volltext

Neuromyelitis optica spectrum disorder related tonic spasms responsive to lacosamide von Brownlee, WJ, Baheerathan, A, Rugg-Gunn, F, Chard, DT, Trip, SA

Volltext

Association of asymptomatic spinal cord lesions and atrophy with disability 5 years after a clinically isolated syndrome von Brownlee, WJ, Altmann, DR, Alves Da Mota, P, Swanton, JK, Miszkiel, KA, Wheeler-Kingshott, Cam Gandini, Ciccarelli, O, Miller, DH

Volltext

Association of asymptomatic spinal cord lesions and atrophy with disability 5 years after a clinically isolated syndrome von Brownlee, WJ, Altmann, DR, Alves Da Mota, P, Swanton, JK, Miszkiel, KA, Wheeler-Kingshott, CG, Ciccarelli, O, Miller, DH

Volltext

COVID-19 and high-efficacy multiple sclerosis therapies: Time for business as usual? von Brownlee, WJ

Volltext bestellen

Very long-term outcome after stroke in Auckland, New Zealand von ANDERSON, Craig S, CARTER, Kristie N, BROWNLEE, Wallace J, HACKETT, Maree L, BROAD, Joanna B, BONITA, Ruth

Volltext

Instead of tweaking the diagnostic criteria for MS in those with CIS, we should develop diagnostic criteria that distinguish MS from other conditions - No von Brownlee, WJ

Volltext bestellen

Do spinal cord lesions matter in patients with clinically isolated syndrome and early MS? von Brownlee, WJ

Volltext bestellen

Use (and misuse) of the McDonald criteria to diagnose multiple sclerosis von Brownlee, WJ

Volltext bestellen

Clinical commentary on 'Late-onset neutropenia and neurological relapse during long-term rituximab therapy in MOG antibody spectrum disorder' von Hacohen, Y, Brownlee, WJ

Volltext bestellen

Switching from natalizumab to alemtuzumab in patients with relapsing multiple sclerosis von John, N, Carroll, A, Brownlee, WJ, Chataway, J

Volltext bestellen

All relapsing multiple sclerosis patients should be managed at a specialist clinic - YES von Brownlee, WJ, Ciccarelli, O

Volltext bestellen

Differential diagnosis of suspected multiple sclerosis: an updated consensus approach von Solomon, AJ, Arrambide, G, Brownlee, WJ, Flanagan, EP, Amato, MP, Amezcua, L, Banwell, BL, Barkhof, F, Corboy, JR, Correale, J, Fujihara, K, Graves, J, Harnegie, MP, Hemmer, B, Lechner-Scott, J, Marrie, RA, Newsome, SD, Rocca, MA, Royal, W, Waubant, EL, Yamout, B, Cohen, JA

Volltext bestellen

New MS diagnostic criteria in practice von De Angelis, F, Brownlee, WJ, Chard, DT, Trip, SA

Volltext bestellen

A practical approach to assessing and managing sexual dysfunction in multiple sclerosis von Li, V, Haslam, C, Pakzad, M, Brownlee, WJ, Panicker, JN

Volltext bestellen

Disease-modifying therapies for multiple sclerosis von De Angelis, F, John, NA, Brownlee, WJ

Volltext bestellen

Early imaging predictors of long-term outcomes in relapse-onset multiple sclerosis von Brownlee, WJ, Altmann, DR, Prados Carrasco, F, Miszkiel, KA, Eshaghi, A, Wheeler-Kingshott, C, Barkhof, F, Ciccarelli, O

Volltext bestellen

Longitudinal assessment of multiple sclerosis with the brain-age paradigm von Cole, JH, Raffel, J, Friede, T, Eshaghi, A, Brownlee, WJ, Chard, D, De Stefano, N, Enzinger, C, Pirpamer, L, Filippi, M, Gasperini, C, Rocca, MA, Rovira, A, Ruggieri, S, Sastre-Garriga, J, Stromillo, ML, Uitdehaag, B, Vrenken, H, Barkhof, F, Nicholas, R, Ciccarelli, O, MAGNIMS study group

Volltext bestellen